Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. (Q54110885)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. |
scientific article |
Statements
Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. (English)
1 reference
1 reference
Baert FJ
1 reference
D'Haens GR
1 reference
Hiele MI
1 reference
Schaible TF
1 reference
Shealy D
1 reference
Geboes K
1 reference
Rutgeerts PJ
1 reference
1 January 1999
1 reference
116
1 reference
22-28
1 reference
1
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference